Compare GKOS & RUSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | RUSHA |
|---|---|---|
| Founded | 1998 | 1965 |
| Country | United States | United States |
| Employees | N/A | 7355 |
| Industry | Medical/Dental Instruments | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.5B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | RUSHA |
|---|---|---|
| Price | $116.56 | $71.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $133.07 | $71.33 |
| AVG Volume (30 Days) | ★ 661.7K | 382.6K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | N/A |
| Revenue This Year | $23.30 | N/A |
| Revenue Next Year | $27.43 | $3.98 |
| P/E Ratio | ★ N/A | $21.36 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $45.67 |
| 52 Week High | $130.23 | $75.99 |
| Indicator | GKOS | RUSHA |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 65.86 |
| Support Level | $104.72 | $69.68 |
| Resistance Level | $123.16 | $75.99 |
| Average True Range (ATR) | 4.70 | 2.16 |
| MACD | 1.71 | 0.77 |
| Stochastic Oscillator | 69.51 | 88.78 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.